As of 2026-06-14, the Relative Valuation of Bio Rad Laboratories Inc (BIO) is 447.64 USD. This relative valuation is based on P/E multiples. With the latest stock price at 285.94 USD, the upside of Bio Rad Laboratories Inc based on Relative Valuation is 56.6%.
The range of the Relative Valuation is 164.13 - 756.36 USD.
| Range | Selected | |
| Trailing P/E multiples | 26.0x - 35.3x | 27.4x |
| Forward P/E multiples | 22.3x - 24.5x | 23.4x |
| Fair Price | 164.13 - 756.36 | 447.64 |
| Upside | -42.6% - 164.5% | 56.6% |
| Date | P/E |
| 2026-06-12 | 45.33 |
| 2026-06-11 | 46.36 |
| 2026-06-10 | 46.13 |
| 2026-06-09 | 47.11 |
| 2026-06-08 | 46.18 |
| 2026-06-05 | 46.66 |
| 2026-06-04 | 48.74 |
| 2026-06-03 | 48.32 |
| 2026-06-02 | 48.53 |
| 2026-06-01 | 48.42 |
| 2026-05-29 | 49.54 |
| 2026-05-28 | 50.45 |
| 2026-05-27 | 48.40 |
| 2026-05-26 | 47.07 |
| 2026-05-22 | 45.62 |
| 2026-05-21 | 45.46 |
| 2026-05-20 | 45.63 |
| 2026-05-19 | 44.56 |
| 2026-05-18 | 44.68 |
| 2026-05-15 | 39.24 |
| 2026-05-14 | 39.04 |
| 2026-05-13 | 38.60 |
| 2026-05-12 | 38.32 |
| 2026-05-11 | 38.65 |
| 2026-05-08 | 40.32 |
| 2026-05-07 | 40.79 |
| 2026-05-06 | 41.06 |
| 2026-05-05 | 40.76 |
| 2026-05-04 | 40.88 |
| 2026-05-01 | 40.67 |
| 2026-04-30 | 44.41 |
| 2026-04-29 | 43.62 |
| 2026-04-28 | 44.28 |
| 2026-04-27 | 45.54 |
| 2026-04-24 | 45.63 |
| 2026-04-23 | 44.61 |
| 2026-04-22 | 47.68 |
| 2026-04-21 | 48.46 |
| 2026-04-20 | 48.09 |
| 2026-04-17 | 47.40 |
| 2026-04-16 | 46.15 |
| 2026-04-15 | 46.92 |
| 2026-04-14 | 46.33 |
| 2026-04-13 | 45.68 |
| 2026-04-10 | 44.27 |
| 2026-04-09 | 43.99 |
| 2026-04-08 | 44.57 |
| 2026-04-07 | 44.07 |
| 2026-04-06 | 44.21 |
| 2026-04-02 | 44.39 |